Resveratrol suppresses melanoma by inhibiting NF-κB/miR-221 and inducing TFG expression

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Resveratrol (Res) is a natural polyphenol with documented anti-cancer properties.
• Melanoma remains a significant health concern, necessitating novel therapeutic strategies.
• MicroRNAs (miRNAs) play crucial roles in cancer development and progression.

Purpose of the Study:

• To investigate the anti-cancer effects of Resveratrol in melanoma.
• To elucidate the role of miRNAs in Resveratrol-mediated melanoma suppression.
• To identify the molecular mechanisms underlying Resveratrol's action in melanoma.

Main Methods:

• In vitro cellular assays and in vivo animal models were employed.
• Quantitative real-time PCR (qRT-PCR) and Western blot analyzed gene and protein expression.
• Dual-luciferase reporter assays and bioinformatic analyses identified miRNA targets.

Main Results:

• Resveratrol significantly inhibited melanoma cell growth in vitro and in vivo.
• Resveratrol treatment led to a decrease in the oncogenic miR-221 expression.
• Resveratrol's mechanism involves regulating NF-κB (RELA) activity and targeting the tumor suppressor gene TFG via miR-221.

Conclusions:

• Resveratrol exhibits potent anti-tumor effects against melanoma.
• The anti-melanoma activity of Resveratrol is mediated through the regulation of miR-221.
• This study reveals a novel molecular pathway involving miR-221, NF-κB, and TFG in Resveratrol's anti-cancer action.